MedTrace Logo

The Association of G9a Protein and Clinical Outcome of Patients With Vulvar Cancer

NCT03695809 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-03-29

No results posted yet for this study

Summary

To assess the G9a expression in vulvar cancer

Conditions

  • Vulvar Cancer, G9a Protein

Interventions

BIOLOGICAL

G9a protein

To assess G9a protein expression on vulvar cancer

Sponsors & Collaborators

  • Gynecologic Oncology Group

    collaborator NETWORK

  • Far Eastern Memorial Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-20
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03695809 on ClinicalTrials.gov